Amarin Eyed by Buyers and 3 Hot Stocks Seeing Action Today
Amarin Corporation plc (NASDAQ:AMRN): Rumors suggest that GlaxoSmithKline (NYSE:GSK) has been considering Illumina (NASDAQ:ILMN), according to the Independent. Roche (RHHBY) denied a bid for Illumina earlier in the year, but traders are convinced that it is possible that Roche may reconsider. Furthermore, rumors have surfaced that Teva (NYSE:TEVA) and AstraZeneca (NYSE:AZN) may be considering bids for Amarin.
Sony Corporation (NYSE:SNE): An increasing amount of U.S. fund managers believe that Japan’s long economic decline is likely to become worse, targeting companies instead. The funds are purchasing credit-default swaps related to the debt of Japan’s electronics makers, which includes Sony and Panasonic (NYSE:PC), and of commodity exporters, like Nippon Paper Group and Kobe Steel (KBSTY), according to the Wall Street Journal.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
Bank of America Corporation (NYSE:BAC): Big banks announced that they’ve cut about 160,000 jobs since early last year, and more layoffs are in the future as the industry restructures, according to Reuters. Many will permanently leave the shrinking sector while redundancies continue to outpace new employees roughly two-to-one. According to a Reuters analysis of job cuts announced by 29 major banks, the lay-offs were much more prominent in Europe than in Asia or the U.S.
Activision Blizzard, Inc. (NASDAQ:ATVI): Activision Publishing, which is a wholly owned subsidiary of Activision Blizzard, announced that Call of Duty: Black Ops II has generated a sell-through totaling over $500 million globally during the first 24 hours it was available, according to Chart-Track, which provides retail customer sell-through information and internal company estimates. The company stated, “With first day sales of over half a billion dollars worldwide, we believe Call of Duty is the biggest entertainment launch of the year for the fourth year in a row…Given the challenged macro-economic environment, we remain cautious about the balance of 2012 and 2013.”